There was an increasing trend of economic losses from cardiovascular and respiratory mortality, which increased from 2.13 billion CNY (95% CI: 0.73–4.11 billion) in 2015 to 2.87 billion CNY (95% CI:0.99–5.52 billion) in 2020 and from 0.22 billion CNY (95% CI: 0–0.46 billion) in 2015 to 0.27 billion CNY (95% CI: 0–0.57 billion) in 2020 (Table 4 and Figure S5 in Supporting Information S1 ).
← all excerpts
A Health Impact and Economic Loss Assessment of O<sub>3</sub> and PM<sub>2.5</sub> Exposure in China From 2015 to 2020.
1
—
—